chrisvoncsefalvay/vaers-outcomes huggingface dataset:
positive person for Covid after receiving the Covid vaccine; positive person for Covid after receiving the Covid vaccine; This is a spontaneous report from a contactable nurse. A patient of unspecified age and gender received bnt162b2 (BNT162B2 also reported as Pfizer-BioNTech COVID-19 Vaccine, lot/batch number and expiry date were unknown), via an unspecified route of administration on unknown date at single dose, for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was a positive person for Covid after receiving the Covid vaccine on an unspecified date. The outcome of the event was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Drug ineffective and COVID-19  cannot be totally excluded.  The case will be reassessed if additional information becomes available.
Suffered an itchy, burning rash all over the left side of her body and was diagnosed with herpes zoster; fever; headache; fatigue; Information has been received from a lawyer, regarding a case in litigation, referring to a female pt of unknown age. Information regarding the pt's pertinent medical history, concurrent conditions, known allergies and concomitant medications was not provided. On or about 25-SEP-2014, the pt was vaccinated with zoster vaccine live (ZOSTAVAX) (route of administration, strength, dose, lot # and expiration date were not provided) for routine health maintenance and for its intended purpose: the prevention of shingles. On an unknown date, shortly after receiving, the pt suffered an itchy, burning rash all over the left side of her body and was diagnosed with herpes zoster. The pt also suffered from fever, headaches, and fatigue during her painful herpes zoster outbreaks. As a direct and proximate result of the pt's use of the zoster vaccine live (ZOSTAVAX) vaccine, symptoms have resulted in physical limitations not present prior to vaccination. The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result, the pt sustained severe, serious, progressive, incurable and permanent personal injuries. At the time of the report, the outcome of herpes zoster, fatigue, headache and pyrexia was considered as not recovered. The lawyer considered herpes zoster, fatigue, headache and pyrexia to be related to Zoster Vaccine Live (ZOSTAVAX). The pt's experiences were considered to be disabling, due to permanent and incurable personal injuries.
I'm aching all over; I'm aching all over mostly in my arm; This case was reported by a consumer via call center representative and described the occurrence of general body pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th February 2020, the patient received the 2nd dose of Shingrix. In February 2020, less than a week after receiving Shingrix, the patient experienced general body pain and pain in arm. On an unknown date, the outcome of the general body pain and pain in arm were unknown.   It was unknown if the reporter considered the general body pain and pain in arm to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The age group was not reported, but was selected adult as per vaccine indication. The patient had aching all over, mostly in arm. The patient asked should he take advil or ibuprofen to ease some of the aches.
Vaccination adverse reaction; This spontaneous case was reported by an other health care professional and describes the occurrence of IMMUNISATION REACTION (Vaccination adverse reaction) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051F22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2023, the patient experienced IMMUNISATION REACTION (Vaccination adverse reaction). At the time of the report, IMMUNISATION REACTION (Vaccination adverse reaction) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   Reporter did not allow further contact
Pt. states that after receiving the 1st dose of Phizer 02/08/2021, immediately felt pain throughout the left arm, Diagnosed Frozen shoulder, PT required 09/17/2021, Primary visit planned 09/20/2021. Initialed by agency given at site.
rash, neck stiffness, neurological issues on injection side, arm pain, neuralgia
Swollen, red, and hot to touch around injection site. Pt. given BENADRYL and using cold compresses. Area was marked and being observed for growth of reaction area.
Patient had reaction in Right shoulder area.  Redness, swelling, and redness.  Treating with over the counter ibuprofen at this time as well as cool compresses.
presented to ED with RUQ pain and temp of 102., borderline SIRS found to have segmental and subsegmental PE's on CT. Additionally diagnosed with UTI
Patient came to get her second Moderna immunization today and stated that she developed a red rash on her arm that she received the first Moderna shot in. She said the rash occured 3 weeks after the immunization and was below the injection site. She noticed it while golfing in another state.
For the first time ever my pulse was erratic, going from 47 to 155.  Then on 2/15, pulse was again erratic, and EKG showed AFib.  Never happened before, no history
7YO patient vaccinated with Boostrix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 7-year-old male patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 31st July 2021, the patient received Boostrix and Boostrix Pre-Filled Syringe Device. On 31st July 2021, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The 7 year old patient was vaccinated with Boostrix, which led to inappropriate age at vaccine administration. The reporter consented to follow up.
Patient was administered expired Covid-19 Moderna Vaccine. Notified Moderna when we were made on 11/17/21 by Health center. Patient has been called and informed of incident and advised to come in and be given an additional full dose of Covid-19 Moderna Vaccine per the instructions of both Moderna an Health center.
Vaccines administered 8/6/16. Presented to office 8/19/16. Mother notice bumps all over body this morning. Also has fever on and off.
First Vaccine in April 2021 and May 2021: Swelling occurred in lymph nodes and in September the swelling became even worse, and the intensity of pain also increased, as well as pain in my chest, prompting me to seek out medical care. The increase in swelling and symptoms lead to more surgeon meetings, Medical Center surgeon and Healthcare, and in November they were going to remove the lymph node, however the size of the lymph node began to reduce, and the surgery was cancelled. I still do have the swelling however the symptoms are no longer consistent however they do come back with stimulation if I do any physical work and lifting heavy objects causes great pain including any stress that comes on will trigger symptoms worsening. Swelling increases as well if physical exertion is done and lymph node swelling has stayed baselined since October in regard to size. I did have a mammogram September 2021, done and they ruled out breast tumors and it showed that lymph nodes were the main culprit. I also had a biopsy done with the lymph node as well.  For about a year I have had cloudy urine. I have now developed swelling in my feet and it gets to a point where it is extremely painful, and I did have to reach out to urgent care due to the pain February 2022. I have been given Lasix as a prescription and try to limit the use. I have had an increase in my A1C as well.
mom was unable to awaken child for 24 hrs; low grade temp; not eating or drinking; PE by MD next morning: nl;
Arm  where received injection still hurting; arm Feels damaged; fingers are cold; arm feels numb,  like the whole arm died; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 2nd November 2022, the patient received the 2nd dose of Shingrix. On 3rd November 2022, 1 days after receiving Shingrix, the patient experienced pain in arm, arm discomfort, fingers cold feeling of and numbness of upper extremities. On an unknown date, the outcome of the pain in arm, arm discomfort, fingers cold feeling of and numbness of upper extremities were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm, arm discomfort, fingers cold feeling of and numbness of upper extremities to be related to Shingrix.     Additional Information: GSK Receipt Date: 11 NOV 2022 Reporter's comment: Reporter was the patient who received her Shingrix dose. Patient stated that her arm where she received the injection was still hurting and while it had gotten better but it felt damaged, numb and the fingers were cold and it felt like the whole arm died, which forced her to switch from right handed to left handed. Patient declined providing her demographics at the beginning of the call and suggested possibility of sharing her contact information towards the end of the call. Patient requested speaking to a supervisor regarding her symptoms and abandoned the call while on hold while agent was assisting with her request, and as such additional adverse event details could not be obtained, including consent for follow up, HCP's information and product details (lot number, expiration date, dose, formulation and route of administration).
Constant complaint of stomach problems, headaches, menstrual cycle totally off, severe abdominal pain, constipation, lethargic, sharp mood swings, no energy.
1:13 pm-Patient  symptoms began  with feeling of about to pass out; patient reclined in drivers side seat of car. Continual monitoring began, staff applied cool wet cloth. -Patient passed out. Patient sweating, clammy feeling. Patient came to, oriented to place, but groggy. While attempting to get B/P, patient passed out a second time.   1:18pm-Client began with wretching body movement, nurse rolled patient to his right side and he began vomiting. (Patient had McDonald?s burgers just prior to shot, vomit appeared to be the undigested food) Patient woke up after began vomiting. Patient coughing, raised patient slightly to sitting position, coughing frequently, congested sounding. Cool cloth kept on forehead. 1:20- B/P 138/74 HR 76, pulse ox 97% on room air (RA). Client stated he felt like he was passing out again, reclined again and syncope followed, lasting only a few seconds and then was awake. 1:28- Cool cloth kept on forehead, B/P 92/54, bounding pulse, HR 62 pulse ox 92% on RA, monitoring continuously, client continued coughing  frequently. 1:33 pt warm, dry. Resting in reclined position. 1:38- patient remains awake and alert B/P 114/66, 98% RA, HR 72, skin warm and dry. Patient talking with wife and nurses. 1:51- B/P 130/78, HR 64, RR 20, 98% RA, coughing decreased, but cough still sounding congested. Bilateral lung sounds clear to auscultation.  1:57- Patient states he feels 85% better than he did a few minutes ago. Cough continues on and off. Client has no current PCP, No history of medical issues. Discussed possibility of aspiration when vomiting during sycopal episode. Advised client to go to urgent care or ER if cough continues, chest pain, difficulty breathing, or fever develops, or experiences another syncopal episode. Patient left for home, with wife driving, at 2:03 pm.
Moderna COVID-19 Vaccine EUA    Extreme itching and rash at shot injection site.
pt had t104, cried long time, high pitched cry, very irritable & listless; cont x 3 days; seen by MD dx febrile reaction w/DTP;
not described in report, vitals: - BP 171/108, HR 87, 100% O2 - BP 171/127, 100% O2
I started 6hrs after the vaccine, got chills, and 8 hours after vaccine got 104.F. Started getting a cough, kept a fever through the night with 102.F.   They did an EKG at the ER.  They sent me home with cough syrup and to go home.  I missed 3 days of work.
DIDN'T FEEL RIGHT; FEELING OF MALAISE; This spontaneous report received from a parent concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced didn't feel right, and feeling of malaise. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from didn't feel right, and feeling of malaise. This report was non-serious. This case, from the same reporter is linked to 20220406074 and 20220407562.
Patient was a transfer from hospital with CC of blurry vision. Ophthalmology team MRI findings revealed  findings consistent with bilateral optic neuritis possibly induced by the influenza vaccination.
PATIENT ADMITTED TO HOSPITAL ON 9/20/21.: ACUTE HYPOXIC RESPIRATORY FAILURE SECONDARY TO COVID 19 PNEUMONIA.  REQUIRING OXYGEN. WIFE ALSO COIVD 19.  DISCHARGED HOME ON 9/27/21.   ADDITIONAL INFORMATION ON HOW PATIENT IS DOING  POST DISHCARGE FROM HOSPITAL WILL NEED TO BE OBTAINED FROM PATIENT.
Large lump with redness and itching. Sore and hot to the touch. Continued for 1 1/2 weeks before I called my physician. She said to apply compresses and cortisone for the itching. The redness spread more so she gave me an antibiotic (Clindamycin) because she thought I might have an infection. The redness has gotten better since I started taking it but the site of the injection is still itchy and red and has not decreased in size.
On the day of vaccination, I started with a fever and all the lymph nodes in my body swelled up and got hard. I was painful to walk so I went to the ER. The hospital ran a bunch of tests. I was given IV fluids, pain medication, and I believe an antibiotic. My body ached very bad. Everything lasted about one week.
i got my period 2x in a given cyclee.  First period started June 1 and I got my 2nd one on June 18
Patient came back to the pharmacy on Feb 16th, 2023, after receiving Pfizer bivalent vaccine on Nov 23rd, 2022. Patient claimed she has nerve damage around injection site (left arm), cannot move her arm laterally since received the vaccine, and has been to several doctor office to treat the condition but claimed to be unsuccessful.  Her husband got the vaccine on the same day without any ADE.
ROTATEQ  was administered after temperature excursion. No additional AE/no PQC.; ROTATEQ  was administered after temperature excursion. No additional AE/no PQC.; This spontaneous report was received from a Medical Assistant referring to a patient of unspecified age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 11-SEP-2023, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, 1 dose, lot #1968393, expiration date: 24-MAY-2024, administered for prophylaxis (strength not provided).  The administered dose of the vaccine experienced a temperature excursion of 8.9 degrees Celsius for 12 hours and 20 minutes, on 14-AUG-2023, and 9.4 degrees Celsius for 8 hours and 20 minutes, on 28-AUG-2023. The vaccines had not had any previous temperature excursions.  There was no adverse effect reported. No product quality complaint was involved.
Patient given FLUZONE in (R) deltoid on 10/19. Upon administration had immediate fairly severe shooting pain in area. Now with persistent pain; intermittent shooting in spite of NAPROSYN & Prednisone.
This spontaneous report as received from nurse practitioner refers to a patient of unknown age and gender. On 27-NOV-2013, the patient was vaccinated with an expired dose of VARIVAX (Merck), 0.5 ml, subcutaneous, lot number reported as 1798AA, expiration date 15-NOV-2013. No adverse effects reported. Additional information has been requested.
Baby received PENTACEL, PREVNAR and ROTATEQ on 3/10/15. Next day on 3/11/15- hives all over no treatment.
difficulty moving arms; painful; This case was reported by a consumer via interactive digital media and described the occurrence of movement disorder in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included PNEUMOCOCCAL VACCINE (PNEUMONIA VACCINE (TRADE NAME UNKNOWN)) for prophylaxis.   On 28th April 2022, the patient received Shingles vaccine and PNEUMONIA VACCINE (TRADE NAME UNKNOWN). On 28th April 2022, less than a day after receiving Shingles vaccine, the patient experienced movement disorder and pain. On an unknown date, the outcome of the movement disorder and pain were unknown.   It was unknown if the reporter considered the movement disorder and pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 28-APR-2022 Reporter's Comment: This case was reported by a consumer via interactive digital media The patient received shingles shot and pneumonia shot on reporting day. Now he/she was having difficulty in moving arm and very painful. Additional Supportive Information:Less than a day, after receiving pneumonia shot , the patient experienced mobility decreased and pain. It was unknown if reporter considered mobility decreased and pain to be related to pneumonia shot. The follow up would not possible as no contact details were available.
considerable pain & swelling in arm, fever, lymph node swollen tender & enlarged-flu like sx-weakness in upper arm-throat problems;
Patient had only received 1 dose in her primary series, was supposed to be getting her 2nd monovalent Pfizer dose. Instead she was given a bivalent Pfizer vaccine. This was an administration error that is required to be reported to VAERS because it is COVID related. No adverse health event occurred.
Pain, swelling under armpit, body aches, blurry vision, fatigue,  chest pain, diarrhea.
1/2 an hour after receiving the vaccine there appeared to be a liquid secreting from my tongue tasting like metal. Later that night I have body aches and was sluggish for about two days after the vaccine. Walking across the room was very tiring.
cold sore; This case was reported by a dentist via call center representative and described the occurrence of cold sores in a 69-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 2nd May 2020, the patient received Shingrix. On 22nd June 2020, 51 days after receiving Shingrix, the patient experienced cold sores. On an unknown date, the outcome of the cold sores was unknown.   It was unknown if the reporter considered the cold sores to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. On 22nd June 2020, the patient experienced cold sore 2 hours prior to the time of reporting.  The patient had never had the cold sore before.  The reporter consent to follow up.
tested positive for COVID19; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for COVID19) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concurrent medical conditions included COVID-19.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for COVID19). At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive for COVID19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information was reported. Treatment information was not reported.
Pt with no previous history of abdominal aortic aneurysm presented to ER on 02.20.2021 with abdominal pain, weakness and BP of 50/30 via EMS. Abdominal pain started on 02.19.2021 approx 10:00 PM. Pain was described as severe in the left flank, radiating into the lower abdomen and worsened through the night. EMS was called around 11 AM.  Pt CT Abd/Pelvis angiography shown Ruptured abdominal aortic aneurysm measuring up to 7.9 cm in diameter and 9.8 cm in length with active extravasation of IV contrast. Large volume of predominantly retroperitoneal hemorrhage. Pt was flown hospital for surgical intervention after being given 2 units of O neg blood with 2 L normal saline.
Pt stated on 9/25/2021 - no previous vaccinations given.  None in EPIC.  GIven 1st Pfizer dose.  On 10/16/2021 Pt's HX now shows 2 Moderna in Jan/Feb 2021.  Verified with pharmacist.  PT referred to pharmacy to resolve.
fatigue, myalgia, fever 103.8, cardiomyalgia, hyponatremia, hypokalemia, hypocalcemia, renal failure, chronic severe fatigue and chronic neuropathic pain shocking to the extremities.
pt recv vax; exp flu like sx w/ a sore throat & generalized aches & pains & devel lt axillary & epitracheal adenopathy;lab eval 31mar94 all nl;
w/in 24 hrs of receiving DT, pt devel temp to 104 w/chills, myalgias & abdo cramping; sx lasted about 3 days; no complaints of local reaction;
never had shingles until she got the vaccine/suspected vaccination failure; had shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: never had shingles until she got the vaccine/suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: had shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 24-MAR-2023  This case was reported by patient's sibling via  interactive digital media.  The patient never had shingles until she got the shingles vaccine. This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Patient called 09/27/20 to report that her arm was practically immobile and she was unable to perform daily tasks with it without having a lot of pain.  An example she gave was that she had not been able to dry her hair in over a week. No PCP on file.  Also gave her the phone number for the National Vaccine Injury Compensation Program.